Improving Metabolic Stability by Glycosylation: Bifunctional Peptide Derivatives That Are Opioid Receptor Agonists and Neurokinin 1 Receptor Antagonists

Overview

Journal J Med Chem

Publisher American Chemical Society

Specialty Chemistry

Date 2010 Jun 22

PMID 20560643

Citations 19

Authors

Takashi Yamamoto

Padma Nair

Neil E Jacobsen

Josef Vagner

Vinod Kulkarni

Peg Davis

Shou-Wu Ma

Edita Navratilova

Henry I Yamamura

Todd W Vanderah

Frank Porreca

Josephine Lai

Victor J Hruby

Affiliations

Soon will be listed here.

Abstract

In order to obtain a metabolically more stable analgesic peptide derivative, O-beta-glycosylated serine (Ser(Glc)) was introduced into TY027 (Tyr-d-Ala-Gly-Phe-Met-Pro-Leu-Trp-NH-3',5'-Bzl(CF(3))(2)) which was a previously reported bifunctional compound with delta/micro opioid agonist and neurokinin-1 receptor antagonist activities and with a half-life of 4.8 h in rat plasma. Incorporation of Ser(Glc) into various positions of TY027 gave analogues with variable bioactivities. Analogue 6 (Tyr-d-Ala-Gly-Phe-Nle-Pro-Leu-Ser(Glc)-Trp-NH-3',5'-Bzl(CF(3))(2)) was found to have effective bifunctional activities with a well-defined conformation with two beta-turns based on the NMR conformational analysis in the presence of DPC micelles. In addition, 6 showed significant improvement in its metabolic stability (70 + or - 9% of 6 was intact after 24 h incubation in rat plasma). This improved metabolic stability, along with its effective and delta selective bifunctional activities, suggests that 6 could be an interesting research tool and possibly a promising candidate as a novel analgesic drug.

Citing Articles

Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics.

Barman P, Joshi S, Sharma S, Preet S, Sharma S, Saini A Int J Pept Res Ther. 2023; 29(4):61.

PMID: 37251528 PMC: 10206374. DOI: 10.1007/s10989-023-10524-3.

Glycopeptide drugs: A pharmacological dimension between "Small Molecules" and "Biologics".

Apostol C, Hay M, Polt R Peptides. 2020; 131:170369.

PMID: 32673700 PMC: 7448947. DOI: 10.1016/j.peptides.2020.170369.

Effects of Cyclization on Activity and Stability of α-Conotoxin TxIB.

Li X, Wang S, Zhu X, Zhangsun D, Wu Y, Luo S Mar Drugs. 2020; 18(4).

PMID: 32235388 PMC: 7230940. DOI: 10.3390/md18040180.

Isolation and characterization of glycosylated neuropeptides.

Liu Y, Cao Q, Li L Methods Enzymol. 2019; 626:147-202.

PMID: 31606074 PMC: 7170398. DOI: 10.1016/bs.mie.2019.07.032.

Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides.

Moradi S, Hussein W, Varamini P, Simerska P, Toth I Chem Sci. 2017; 7(4):2492-2500.

PMID: 28660018 PMC: 5477030. DOI: 10.1039/c5sc04392a.

References

Sawyer T, Sanfilippo P, Hruby V, Engel M, Heward C, Burnett J . 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci U S A. 1980; 77(10):5754-8. PMC: 350149. DOI: 10.1073/pnas.77.10.5754. View

Albert R, Marbach P, BAUER W, Briner U, Fricker G, Bruns C . SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity. Life Sci. 1993; 53(6):517-25. DOI: 10.1016/0024-3205(93)90703-6. View

DAlagni M, Delfini M, Di Nola A, Eisenberg M, Paci M, Roda L . Conformational study of [Met5]enkephalin-Arg-Phe in the presence of phosphatidylserine vesicles. Eur J Biochem. 1996; 240(3):540-9. DOI: 10.1111/j.1432-1033.1996.0540h.x. View

Ma W, Zheng W, Kar S, Quirion R . Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons. Neuroscience. 2000; 99(3):529-39. DOI: 10.1016/s0306-4522(00)00226-8. View

Cirino P, Tang Y, Takahashi K, Tirrell D, Arnold F . Global incorporation of norleucine in place of methionine in cytochrome P450 BM-3 heme domain increases peroxygenase activity. Biotechnol Bioeng. 2003; 83(6):729-34. DOI: 10.1002/bit.10718. View

Live D, Williams L, Kuduk S, Schwarz J, Glunz P, Chen X . Probing cell-surface architecture through synthesis: an NMR-determined structural motif for tumor-associated mucins. Proc Natl Acad Sci U S A. 1999; 96(7):3489-93. PMC: 22319. DOI: 10.1073/pnas.96.7.3489. View

HANSCH C, Dunn 3rd W . Linear relationships between lipophilic character and biological activity of drugs. J Pharm Sci. 1972; 61(1):1-19. DOI: 10.1002/jps.2600610102. View

Lis H, Sharon N . Protein glycosylation. Structural and functional aspects. Eur J Biochem. 1993; 218(1):1-27. DOI: 10.1111/j.1432-1033.1993.tb18347.x. View

Millet R, Domarkas J, Rigo B, Goossens L, Goossens J, Houssin R . Novel potent substance P and neurokinin A receptor antagonists. Conception, synthesis and biological evaluation of indolizine derivatives. Bioorg Med Chem. 2002; 10(9):2905-12. DOI: 10.1016/s0968-0896(02)00144-x. View

10.

Jacobsen N, Abadi N, Sliwkowski M, Reilly D, Skelton N, Fairbrother W . High-resolution solution structure of the EGF-like domain of heregulin-alpha. Biochemistry. 1996; 35(11):3402-17. DOI: 10.1021/bi952626l. View

11.

Matsumori N, Houdai T, Murata M . Conformation and position of membrane-bound amphotericin B deduced from NMR in SDS micelles. J Org Chem. 2007; 72(3):700-6. DOI: 10.1021/jo061309p. View

12.

Misterek K, Maszczynska I, Dorociak A, Gumulka S, Carr D, Szyfelbein S . Spinal co-administration of peptide substance P antagonist increases antinociceptive effect of the opioid peptide biphalin. Life Sci. 1994; 54(14):939-44. DOI: 10.1016/0024-3205(94)00494-3. View

13.

Chang K, Rigdon G, Howard J, McNutt R . A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86. J Pharmacol Exp Ther. 1993; 267(2):852-7. View

14.

King T, Gardell L, Wang R, Vardanyan A, Ossipov M, Malan Jr P . Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain. 2005; 116(3):276-288. PMC: 1440305. DOI: 10.1016/j.pain.2005.04.014. View

15.

Deber C, Behnam B . Role of membrane lipids in peptide hormone function: binding of enkephalins to micelles. Proc Natl Acad Sci U S A. 1984; 81(1):61-5. PMC: 344610. DOI: 10.1073/pnas.81.1.61. View

16.

Sargent D, BEAN J, SCHWYZER R . Conformation and orientation of regulatory peptides on lipid membranes. Key to the molecular mechanism of receptor selection. Biophys Chem. 1988; 31(1-2):183-93. DOI: 10.1016/0301-4622(88)80024-3. View

17.

Yamamoto T, Nair P, Jacobsen N, Davis P, Ma S, Navratilova E . The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists. J Med Chem. 2008; 51(20):6334-47. PMC: 2675940. DOI: 10.1021/jm800389v. View

18.

Wishart D, Sykes B, Richards F . The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry. 1992; 31(6):1647-51. DOI: 10.1021/bi00121a010. View

19.

Quartara L, Fabbri G, Ricci R, Patacchini R, Pestellini V, Maggi C . Influence of lipophilicity on the biological activity of cyclic pseudopeptide NK-2 receptor antagonists. J Med Chem. 1994; 37(21):3630-8. DOI: 10.1021/jm00047a020. View

20.

McManus A, Otvos Jr L, Hoffmann R, Craik D . Conformational studies by NMR of the antimicrobial peptide, drosocin, and its non-glycosylated derivative: effects of glycosylation on solution conformation. Biochemistry. 1999; 38(2):705-14. DOI: 10.1021/bi981956d. View